ŽUREK, Jiří, Michal KÝR, Martin VAVŘINA and Michal FEDORA. Trefoil factor 3 as a marker of intestinal cell damage during sepsis. Open Medicine. Warsaw: Walter De Gruyter, 2015, vol. 10, No 1, p. 261-266. ISSN 2391-5463. Available from: https://dx.doi.org/10.1515/med-2015-0020.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Trefoil factor 3 as a marker of intestinal cell damage during sepsis
Authors ŽUREK, Jiří (203 Czech Republic, guarantor, belonging to the institution), Michal KÝR (203 Czech Republic, belonging to the institution), Martin VAVŘINA (203 Czech Republic, belonging to the institution) and Michal FEDORA (203 Czech Republic, belonging to the institution).
Edition Open Medicine, Warsaw, Walter De Gruyter, 2015, 2391-5463.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30209 Paediatrics
Country of publisher Poland
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14110/15:00082863
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1515/med-2015-0020
UT WoS 000371696900021
Keywords in English Trefoil factor; gut injury; sepsis; children; mortality
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Ing. Mgr. Věra Pospíšilíková, učo 9005. Changed: 22/4/2016 14:33.
Abstract
Objective: Gastrointestinal dysfunction or gut failure frequently occurs in seriously ill patients and can be responsible for multi-organ failure. Trefoil factor 3 (TFF3) was characterized for its role in reconstitution of an epithelial barrier after mucosal injury in the jejunum. The aims of our study was an analysis of TFF3 levels dynamics in patients with sepsis and the correlation of TFF3 with severity of sepsis and mortality. Methods: Prospective observational study, a ten days evaluation period in children aged 0-19 years with systemic inflammatory response syndrome or septic state. Blood tests to determine levels of TFF3 were obtained as long as the patient met the criteria for systemic inflammatory response syndrome or sepsis. Results: Analysis of dynamics revealed steady levels of TFF3 during the 10 day period evaluated. TFF3 levels could not differentiate between various septic conditions in patients until a marked organ dysfunction developed. Higher Area Under Curve was noticed between control group and patients with sepsis. We could not make any strong conclusions based on mortality model. Conclusions: Levels of TFF3 are elevated in paediatric patients with sepsis through organ dysfunction.
PrintDisplayed: 11/10/2024 17:09